The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Fine Chemicals-Global Market Insights and Sales Trends 2025
Synopsis
Pharmaceutical fine chemicals can be broadly defined as the set of products—intermediates and finished API, or active pharmaceutical ingredients—as well as related services like process development and optimization associated with the access by pharmaceutical companies to the drug substance (API) throughout the product life cycle excluding pre-clinical development.
The global Pharmaceutical Fine Chemicals market size is expected to reach US$ 155620 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Fine Chemicals in various end use industries. The expanding demands from the Third Party Vendors, Emerging Pharmaceutical Companies and Established Pharmaceutical Companies,, are propelling Pharmaceutical Fine Chemicals market. Large Molecules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Small Molecules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Fine Chemicals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Fine Chemicals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Fine Chemicals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Fine Chemicals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Fine Chemicals covered in this report include Lonza, CML, FIS, Hovione, Bachem, Helsinn Advanced Synthesis, Umicore, Sifavitor (Infa Group) and Chemo, etc.
The global Pharmaceutical Fine Chemicals market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza
CML
FIS
Hovione
Bachem
Helsinn Advanced Synthesis
Umicore
Sifavitor (Infa Group)
Chemo
W.R. Grace
Kenko Corporation
Albemarle Corporation
Denisco Chemicals
Chemada Fine Chemicals
Syntor Fine Chemicals
Johnson Matthey Fine Chemicals
Global Pharmaceutical Fine Chemicals market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Fine Chemicals market, Segment by Type:
Large Molecules
Small Molecules
Global Pharmaceutical Fine Chemicals market, by Application
Third Party Vendors
Emerging Pharmaceutical Companies
Established Pharmaceutical Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Fine Chemicals companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pharmaceutical fine chemicals can be broadly defined as the set of products—intermediates and finished API, or active pharmaceutical ingredients—as well as related services like process development and optimization associated with the access by pharmaceutical companies to the drug substance (API) throughout the product life cycle excluding pre-clinical development.
The global Pharmaceutical Fine Chemicals market size is expected to reach US$ 155620 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Fine Chemicals in various end use industries. The expanding demands from the Third Party Vendors, Emerging Pharmaceutical Companies and Established Pharmaceutical Companies,, are propelling Pharmaceutical Fine Chemicals market. Large Molecules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Small Molecules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Fine Chemicals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Fine Chemicals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Fine Chemicals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Fine Chemicals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Fine Chemicals covered in this report include Lonza, CML, FIS, Hovione, Bachem, Helsinn Advanced Synthesis, Umicore, Sifavitor (Infa Group) and Chemo, etc.
The global Pharmaceutical Fine Chemicals market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza
CML
FIS
Hovione
Bachem
Helsinn Advanced Synthesis
Umicore
Sifavitor (Infa Group)
Chemo
W.R. Grace
Kenko Corporation
Albemarle Corporation
Denisco Chemicals
Chemada Fine Chemicals
Syntor Fine Chemicals
Johnson Matthey Fine Chemicals
Global Pharmaceutical Fine Chemicals market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Fine Chemicals market, Segment by Type:
Large Molecules
Small Molecules
Global Pharmaceutical Fine Chemicals market, by Application
Third Party Vendors
Emerging Pharmaceutical Companies
Established Pharmaceutical Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Fine Chemicals companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Fine Chemicals
1.1 Pharmaceutical Fine Chemicals Market Overview
1.1.1 Pharmaceutical Fine Chemicals Product Scope
1.1.2 Pharmaceutical Fine Chemicals Market Status and Outlook
1.2 Global Pharmaceutical Fine Chemicals Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Fine Chemicals Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Fine Chemicals Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Fine Chemicals Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Fine Chemicals Market Size (2018-2029)
1.6.1 North America Pharmaceutical Fine Chemicals Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Fine Chemicals Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Fine Chemicals Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Fine Chemicals Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Fine Chemicals Market Size (2018-2029)
2 Pharmaceutical Fine Chemicals Market by Type
2.1 Introduction
2.1.1 Large Molecules
2.1.2 Small Molecules
2.2 Global Pharmaceutical Fine Chemicals Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Fine Chemicals Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Fine Chemicals Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Fine Chemicals Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Fine Chemicals Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Fine Chemicals Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Fine Chemicals Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Fine Chemicals Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Fine Chemicals Market Overview by Application
3.1 Introduction
3.1.1 Third Party Vendors
3.1.2 Emerging Pharmaceutical Companies
3.1.3 Established Pharmaceutical Companies
3.2 Global Pharmaceutical Fine Chemicals Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Fine Chemicals Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Fine Chemicals Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Fine Chemicals Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Fine Chemicals Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Fine Chemicals Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Fine Chemicals Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Fine Chemicals Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Fine Chemicals Competition Analysis by Players
4.1 Global Pharmaceutical Fine Chemicals Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Fine Chemicals as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Fine Chemicals Market
4.4 Global Top Players Pharmaceutical Fine Chemicals Headquarters and Area Served
4.5 Key Players Pharmaceutical Fine Chemicals Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Fine Chemicals Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Pharmaceutical Fine Chemicals Products, Services and Solutions
5.1.4 Lonza Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.1.5 Lonza Recent Developments
5.2 CML
5.2.1 CML Profile
5.2.2 CML Main Business
5.2.3 CML Pharmaceutical Fine Chemicals Products, Services and Solutions
5.2.4 CML Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.2.5 CML Recent Developments
5.3 FIS
5.3.1 FIS Profile
5.3.2 FIS Main Business
5.3.3 FIS Pharmaceutical Fine Chemicals Products, Services and Solutions
5.3.4 FIS Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.3.5 Hovione Recent Developments
5.4 Hovione
5.4.1 Hovione Profile
5.4.2 Hovione Main Business
5.4.3 Hovione Pharmaceutical Fine Chemicals Products, Services and Solutions
5.4.4 Hovione Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.4.5 Hovione Recent Developments
5.5 Bachem
5.5.1 Bachem Profile
5.5.2 Bachem Main Business
5.5.3 Bachem Pharmaceutical Fine Chemicals Products, Services and Solutions
5.5.4 Bachem Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.5.5 Bachem Recent Developments
5.6 Helsinn Advanced Synthesis
5.6.1 Helsinn Advanced Synthesis Profile
5.6.2 Helsinn Advanced Synthesis Main Business
5.6.3 Helsinn Advanced Synthesis Pharmaceutical Fine Chemicals Products, Services and Solutions
5.6.4 Helsinn Advanced Synthesis Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.6.5 Helsinn Advanced Synthesis Recent Developments
5.7 Umicore
5.7.1 Umicore Profile
5.7.2 Umicore Main Business
5.7.3 Umicore Pharmaceutical Fine Chemicals Products, Services and Solutions
5.7.4 Umicore Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.7.5 Umicore Recent Developments
5.8 Sifavitor (Infa Group)
5.8.1 Sifavitor (Infa Group) Profile
5.8.2 Sifavitor (Infa Group) Main Business
5.8.3 Sifavitor (Infa Group) Pharmaceutical Fine Chemicals Products, Services and Solutions
5.8.4 Sifavitor (Infa Group) Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.8.5 Sifavitor (Infa Group) Recent Developments
5.9 Chemo
5.9.1 Chemo Profile
5.9.2 Chemo Main Business
5.9.3 Chemo Pharmaceutical Fine Chemicals Products, Services and Solutions
5.9.4 Chemo Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.9.5 Chemo Recent Developments
5.10 W.R. Grace
5.10.1 W.R. Grace Profile
5.10.2 W.R. Grace Main Business
5.10.3 W.R. Grace Pharmaceutical Fine Chemicals Products, Services and Solutions
5.10.4 W.R. Grace Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.10.5 W.R. Grace Recent Developments
5.11 Kenko Corporation
5.11.1 Kenko Corporation Profile
5.11.2 Kenko Corporation Main Business
5.11.3 Kenko Corporation Pharmaceutical Fine Chemicals Products, Services and Solutions
5.11.4 Kenko Corporation Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.11.5 Kenko Corporation Recent Developments
5.12 Albemarle Corporation
5.12.1 Albemarle Corporation Profile
5.12.2 Albemarle Corporation Main Business
5.12.3 Albemarle Corporation Pharmaceutical Fine Chemicals Products, Services and Solutions
5.12.4 Albemarle Corporation Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.12.5 Albemarle Corporation Recent Developments
5.13 Denisco Chemicals
5.13.1 Denisco Chemicals Profile
5.13.2 Denisco Chemicals Main Business
5.13.3 Denisco Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
5.13.4 Denisco Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.13.5 Denisco Chemicals Recent Developments
5.14 Chemada Fine Chemicals
5.14.1 Chemada Fine Chemicals Profile
5.14.2 Chemada Fine Chemicals Main Business
5.14.3 Chemada Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
5.14.4 Chemada Fine Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.14.5 Chemada Fine Chemicals Recent Developments
5.15 Syntor Fine Chemicals
5.15.1 Syntor Fine Chemicals Profile
5.15.2 Syntor Fine Chemicals Main Business
5.15.3 Syntor Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
5.15.4 Syntor Fine Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.15.5 Syntor Fine Chemicals Recent Developments
5.16 Johnson Matthey Fine Chemicals
5.16.1 Johnson Matthey Fine Chemicals Profile
5.16.2 Johnson Matthey Fine Chemicals Main Business
5.16.3 Johnson Matthey Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
5.16.4 Johnson Matthey Fine Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2018-2023)
5.16.5 Johnson Matthey Fine Chemicals Recent Developments
6 North America
6.1 North America Pharmaceutical Fine Chemicals Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Fine Chemicals Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Fine Chemicals Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Fine Chemicals Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Fine Chemicals Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Fine Chemicals Market Dynamics
11.1 Pharmaceutical Fine Chemicals Industry Trends
11.2 Pharmaceutical Fine Chemicals Market Drivers
11.3 Pharmaceutical Fine Chemicals Market Challenges
11.4 Pharmaceutical Fine Chemicals Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
